Our recognition
Latest stories
Featured
Hikma delivers strong 2023 performance and a positive outlook for 2024
Press Release, Financial Results
22 February 2024
- Hikma remains a constituent of the FTSE4Good Index Press Release, Corporate 16 July 2025 Hikma remains a constituent of the FTSE4Good Index
- Hikma launches Morphine Sulfate Injection, USP, in a prefilled syringe in the US Press Release, Product 14 July 2025 Hikma launches Morphine Sulfate Injection, USP, in a prefilled syringe in the US
- Notice of results Press Release, Financial Results 09 July 2025 Notice of results
- Supporting communities globally: Highlights from our 2025 Global Volunteer Campaign Story, Responsibility 03 July 2025 Supporting communities globally: Highlights from our 2025 Global Volunteer Campaign
Related content